Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHRP-6

Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

Quick Stats
Studies 702
Trials 0
Score 3
2016 pubmed 10 citations

Impact of [d-Lys(3)]-GHRP-6 and feeding status on hypothalamic ghrelin-induced stress activation.

Brockway. Emma T ET; Krater. Katherine R KR; Selva. Joaquín A JA; Wauson. Shelby E R SE; Currie. Paul J PJ

Key Findings

  • Injecting ghrelin into hypothalamic areas (ArcN and PVN) triggers anxiety-like behavior in rats.
  • Pretreating with the ghrelin‑1a receptor antagonist [d-Lys(3)]-GHRP-6 blocks the anxiety effect.
  • Having food available before testing reverses the anxiety, whereas fasting enhances it.

Practical Outcomes

  • If you use GHRP‑6 (a ghrelin‑receptor agonist) for growth hormone release, taking it on an empty stomach might increase stress or anxiety. Pairing the peptide with a meal could blunt these mood effects. Conversely, a ghrelin‑receptor blocker could be explored to counteract anxiety if needed.

Summary

The study shows that activating ghrelin receptors in the brain can make rats more anxious, but blocking those receptors with the antagonist [d-Lys(3)]-GHRP-6 reduces the anxiety. Whether the animals have eaten or not also matters – eating right before testing stops the anxiety, while staying fasted makes it worse.

Abstract

Ghrelin administration directly into hypothalamic nuclei, including the arcuate nucleus (ArcN) and the paraventricular nucleus (PVN), alters the expression of stress-related behaviors. In the present study we investigated the effect of feeding status on the ability of ghrelin to induce stress and anxiogenesis. Adult male Sprague Dawley rats were implanted with guide cannula targeting either the ArcN or PVN. In the first experiment we confirmed that ArcN and PVN ghrelin treatment produced anxiety-like behavior as measured using the elevated plus maze (EPM) paradigm. Ghrelin was administered during the early dark cycle. Immediately after microinjections rats were placed in the EPM for 5min. Both ArcN and PVN treatment reduced open arm exploration. The effect was attenuated by pretreatment with the ghrelin 1a receptor antagonist [d-Lys(3)]-GHRP-6. In a separate group of animals ghrelin was injected into either nucleus and rats were returned to their home cages for 60min with free access to food. An additional group of rats was returned to home cages with no food access. After 60min with or without food access all rats were tested in the EPM. Results indicated that food consumption just prior to EPM testing reversed the avoidance of the open arms of the EPM. In contrast, rats injected with ghrelin, placed in their home cage for 60min without food, and subsequently tested in the EPM, exhibited an increased avoidance of the open arms, consistent with stress activation. Overall, our findings demonstrate that ghrelin 1a receptor blockade and feeding status appear to impact the ability of ArcN and PVN ghrelin to elicit stress and anxiety-like behaviors.

Study Information

Provider

pubmed

Year

2016

Date

2016-03-26T00:00:00.000Z

DOI

10.1016/j.peptides.2016.03.013

Citations

10

References

68